glp-1 therapy mandeville People ask if GLP-1s work in type 1 diabetes. Yes. But not just for weight loss. In ADJUST-T1D: 36% of patients achieved TIR >70%, TBR <4%, and ≥5% weight loss simultaneously. Zero GLP-1-based therapies don't specifically cause

Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea

Ma Z, Jin K, Yue M, Chen X, Chen J

What Clinical Studies Suggest Clinical studies have shown that tirzepatide can help reduce HbA1c levels and support greater weight loss compared with semaglutide 1 mg in adults with type 2 diabetes

& Ludwig, D

How high-protein, nutrient-dense, portion-controlled foods are shaping the future of metabolic health GLP-1 receptor agonists like Ozempic, Wegovy and Mounjaro are reshaping how millions of people eat

For context on peptides relevant to metabolic research applications, explore our peptides for gut health research guide